Alvegesic Vet. 10 mg/ml Solution for Injection for Horses, Dogs and Cats

Negara: Inggris

Bahasa: Inggris

Sumber: VMD (Veterinary Medicines Directorate)

Beli Sekarang

Unduh Karakteristik produk (SPC)
23-05-2023

Bahan aktif:

Butorphanol

Tersedia dari:

VMD NV

Kode ATC:

QN02AF01

INN (Nama Internasional):

Butorphanol

Bentuk farmasi:

Solution for injection

Jenis Resep:

POM-V - Prescription Only Medicine – Veterinarian

Kelompok Terapi:

Cats, Dogs, Horses

Area terapi:

Neurological Agent analgesic

Status otorisasi:

Authorized

Tanggal Otorisasi:

2009-09-02

Karakteristik produk

                                Revised: October 2020
AN: 00793/2020
Page 1 of 11
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs and
Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml solution for injection contains:
Active substance:
Butorphanol
10.00 mg
(equivalent to Butorphanol tartrate
14.58 mg)
Excipients:
Benzethonium chloride
0.10 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection
Clear, colourless solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horse, Dog, Cat.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
HORSE
As
an
analgesic:
For
relief
of
moderate
to
severe
abdominal
pain
(alleviates
abdominal pain associated with colic of gastrointestinal origin).
As a sedative: For sedation after the administration of certain
alpha2-adrenoceptor
agonists (detomidine, romifidine).
DOG
As an analgesic: For relief of moderate visceral pain.
As a sedative: For sedation in combination with certain
alpha2-adrenoceptor agonists
(medetomidine).
As a pre-anaesthetic: For pre-anaesthesia as sole agent and in
combination with
acepromazine.
As an anaesthetic: For anaesthesia in combination with medetomidine
and ketamine.
CAT
As an analgesic for the relief of moderate pain: For pre-operative
analgesia in
combination with acepromazine/ketamine or xylazine/ketamine.
For post- operative analgesia after small surgical procedures.
As a sedative: For sedation in combination with certain
alpha2-adrenoceptor agonists
(medetomidine).
As an anaesthetic: For anaesthesia in combination with medetomidine
and ketamine.
Revised: October 2020
AN: 00793/2020
Page 2 of 11
4.3
CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active substance
or to any of the
excipients.
Do not use in animals with severe dysfunction of the liver or kidneys.
Use of butorphanol is contraindicated in case of cerebral injury or
organic brain
lesions and in animals with obstructive respiratory disease, heart
dysfunction or
                                
                                Baca dokumen lengkapnya
                                
                            

Peringatan pencarian terkait dengan produk ini